Age-related declines in delayed non-match-to-sample performance (DNMS) are reversed by the novel 5HT6 receptor antagonist SB742457

Charlotte K. Callaghan, Vincent Hok, Andrea Della-Chiesa, David J. Virley, Neil Upton, Shane M. O'Mara
  • Neuropharmacology, October 2012, Elsevier
  • DOI: 10.1016/j.neuropharm.2012.06.034

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1016/j.neuropharm.2012.06.034

The following have contributed to this page: Professor Shane M O'Mara